Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Current Assets (2018 - 2026)

Select Medical Holdings (SEM) has disclosed Current Assets for 9 consecutive years, with $1.1 billion as the latest value for Q1 2026.

  • For Q1 2026, Current Assets rose 1.81% year-over-year to $1.1 billion; the TTM value through Mar 2026 reached $1.1 billion, up 1.81%, while the annual FY2025 figure was $1.0 billion, 0.54% up from the prior year.
  • Current Assets hit $1.1 billion in Q1 2026 for Select Medical Holdings, up from $1.0 billion in the prior quarter.
  • Across five years, Current Assets topped out at $1.4 billion in Q1 2024 and bottomed at $1.0 billion in Q4 2024.
  • Average Current Assets over 5 years is $1.2 billion, with a median of $1.3 billion recorded in 2022.
  • On a YoY basis, Current Assets climbed as much as 11.57% in 2022 and fell as far as 34.64% in 2022.
  • Select Medical Holdings' Current Assets stood at $1.3 billion in 2022, then fell by 1.08% to $1.3 billion in 2023, then decreased by 18.91% to $1.0 billion in 2024, then increased by 0.54% to $1.0 billion in 2025, then increased by 8.47% to $1.1 billion in 2026.
  • According to Business Quant data, Current Assets over the past three periods came in at $1.1 billion, $1.0 billion, and $1.0 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.